Efficacy and safety of SYSA1902 versus reference ustekinumab in moderate-to-severe plaque psoriasis: a multicenter, randomized, phase III study

Name: Efficacy and safety of SYSA1902 versus reference ustekinumab in moderate-to-severe plaque psoriasis: a multicenter, randomized, phase III study
Creator: Lei Wang
Published: 2025-02-28T16:06:05.640Z
Keywords: Clinical Trial, Psoriasis, Phase III Trials